$4,880.85 travel Payment -- Eli Lilly and Company to Dr. Michelle Scott

Eli Lilly and Company covers travel and lodging for Endocrinologist Michelle Scott for Tagrisso.

This page provides a detailed analysis of a $4,880.85 travel payment from Eli Lilly and Company to Dr. Michelle Scott. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$4,880.85
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyEli Lilly and Company
PhysicianDr. Michelle Scott
NPI Number1286042823
Physician SpecialtyEndocrinology
LocationCity, AL
Date of Payment2024-07-27
Related Drug/DeviceTagrisso
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Eli Lilly and Company made a $4.9K travel payment to Michelle Scott, a Endocrinology specialist in City, AL. The payment was associated with Tagrisso. The payment of $4,880.85 to Dr. Michelle Scott by Eli Lilly and Company is for travel and lodging related to Tagrisso. This payment occurred on July 27, 2024, and was made to an Endocrinologist in Alabama. The payment ID is OP-MNKGT0PK-E8ZV97, linking it to a specific transaction.

Patient Guidance: What This Payment Means for You

This payment covers travel and lodging expenses, which may be related to educational events or professional development concerning a medication. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments to physicians can vary widely depending on the nature of the event, location, and duration. Endocrinologists may receive such payments for conferences or educational programs relevant to their practice.

Regulatory Context: Sunshine Act Requirements

Payments made by pharmaceutical companies to physicians for travel and lodging are subject to disclosure under the Sunshine Act (part of the Affordable Care Act) to ensure transparency in the healthcare industry.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.9K payment for?

This was a travel payment of $4.9K from Eli Lilly and Company to Michelle Scott, categorized as "Travel and Lodging". It was associated with Tagrisso. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Michelle Scott accept pharmaceutical money?

Yes, Michelle Scott received this $4.9K payment from Eli Lilly and Company. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Michelle Scott's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.9K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Endocrinology?

To compare this payment against Endocrinology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Endocrinology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Michelle Scott's relationship with Eli Lilly and Company?

The payment amount is substantial, suggesting a multi-day trip or significant travel expenses. This $4.9K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Endocrinology?

The payment is specifically for 'Travel and Lodging', indicating it's not for speaking fees or consulting.

What should patients do after learning about this payment?

This payment covers travel and lodging expenses, which may be related to educational events or professional development concerning a medication.

What else should I know about this travel payment?

The drug associated, Tagrisso, is a targeted therapy for non-small cell lung cancer, suggesting the travel may be related to educational events or clinical trial support.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.